Currently at a historic resistance point so wouldn't be surprised if it were to consolidate for a while. Shouldn't affect MMB too much as the longer term picture seems bullish atm.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%